Nanopharmaceuticals are colloidal particles of 10 to 1,000 nanometers (1 micron) in size. They are widely used in drug delivery. Nanopharmaceuticals are diverse both in their shape and composition and often offer an advantage as compared to their ﾓbulkﾔ counterparts primarily because of size. There are two types of nanopharmaceuticals: (1) those where the therapeutic molecules are themselves the drug (i.e.,the therapeutic compound itself also functions as its own carrier); and (2) those where the therapeutic molecules are directly coupled (functionalized, entrapped, or coated) to a nanoparticle carrier. According to our (Global Info Research) latest study, the global Nanopharmaceuticals market size was valued at USD 31860 million in 2022 and is forecast to a readjusted size of USD 72390 million by 2029 with a CAGR of 12.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. USA is the largest Nanopharmaceuticals market with about 59% market share. Europe is follower, accounting for about 33% market share. The key players are Merck, Pfizer, Novartis, Abbott, GlaxoSmithKline, Roche, Sanofi, Eli Lilly, Astrazeneca, Johnson & Johnson, Celgene, Novavax, Stryker, Gilead Sciences, OSI Pharmaceuticals, Kadmon Pharmaceuticals, Samyang Biopharm, Mitsubishi Pharma, Kaken Pharmaceutical, Selecta Biosciences, Par Pharmaceutical, Cerulean Pharma, Navidea Biopharmaceuticals, Lummy etc. Top 3 companies occupied about 34% market share. This report is a detailed and comprehensive analysis for global Nanopharmaceuticals market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided. Key Features: Global Nanopharmaceuticals market size and forecasts, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2018-2029 Global Nanopharmaceuticals market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2018-2029 Global Nanopharmaceuticals market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2018-2029 Global Nanopharmaceuticals market shares of main players, shipments in revenue ($ Million), sales quantity (K MT), and ASP (USD/MT), 2018-2023 The Primary Objectives in This Report Are: To determine the size of the total market opportunity of global and key countries To assess the growth potential for Nanopharmaceuticals To forecast future growth in each product and end-use market To assess competitive factors affecting the marketplace This report profiles key players in the global Nanopharmaceuticals market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Pfizer, Novartis, Abbott and GlaxoSmithKline, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence. Market Segmentation Nanopharmaceuticals market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets. Market segment by Type Liposomes Polymeric Micelles Solid Lipid Nanoparticles Microemulsion and Nnanoemulsion Nanosuspension Market segment by Application Cancer and Tumor Autoimmune Disorders Inflammation Others Major players covered Merck Pfizer Novartis Abbott GlaxoSmithKline Roche Sanofi Eli Lilly Astrazeneca Johnson & Johnson Celgene Novavax Stryker Gilead Sciences OSI Pharmaceuticals Kadmon Pharmaceuticals Samyang Biopharm Mitsubishi Pharma Kaken Pharmaceutical Selecta Biosciences Par Pharmaceutical Cerulean Pharma Navidea Biopharmaceuticals Lummy Market segment by region, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia) South America (Brazil, Argentina, Colombia, and Rest of South America) Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa) The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Nanopharmaceuticals product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top manufacturers of Nanopharmaceuticals, with price, sales, revenue and global market share of Nanopharmaceuticals from 2018 to 2023. Chapter 3, the Nanopharmaceuticals competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Nanopharmaceuticals breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029. Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029. Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Nanopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029. Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War. Chapter 13, the key raw materials and key suppliers, and industry chain of Nanopharmaceuticals. Chapter 14 and 15, to describe Nanopharmaceuticals sales channel, distributors, customers, research findings and conclusion.
1 Market Overview 1.1 Product Overview and Scope of Nanopharmaceuticals 1.2 Market Estimation Caveats and Base Year 1.3 Market Analysis by Type 1.3.1 Overview: Global Nanopharmaceuticals Consumption Value by Type: 2018 Versus 2022 Versus 2029 1.3.2 Liposomes 1.3.3 Polymeric Micelles 1.3.4 Solid Lipid Nanoparticles 1.3.5 Microemulsion and Nnanoemu
